Skip to main content

Peer Review reports

From: Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial

Original Submission
26 Mar 2022 Submitted Original manuscript
21 May 2022 Reviewed Reviewer Report
17 Jun 2022 Reviewed Reviewer Report
1 Jul 2022 Author responded Author comments - Tingbo Liang
Resubmission - Version 2
1 Jul 2022 Submitted Manuscript version 2
3 Jul 2022 Author responded Author comments - Tingbo Liang
Resubmission - Version 3
3 Jul 2022 Submitted Manuscript version 3
Publishing
20 Jul 2022 Editorially accepted
8 Aug 2022 Article published 10.1186/s12885-022-09974-7

You can find further information about peer review here.

Back to article page